← FDA Drug Approvals (Drugs@FDA)
RALTEGRAVIR POTASSIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2025-05-06
Drug application
- FDA Application #
ANDA217990- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RALTEGRAVIR POTASSIUM
- Generic name
- Raltegravir Potassium
- Active ingredients
- RALTEGRAVIR POTASSIUM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- LUPIN
- First approval
- 2025-05-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown